SEC Filing Summary: Nephros, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Nephros, Inc. on May 17, 2005. The report serves as a current disclosure under Regulation FD, providing shareholders with the company's 2004 Annual Report. This filing coincides with the mailing of the Notice of Annual Meeting, Proxy Statement, and the Annual Report on Form 10-KSB.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached 2004 Annual Report (Exhibit 13.1), which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
No material changes to financial performance or operations are described in the text of this filing. The document acts solely as a vehicle to distribute the previously prepared 2004 Annual Report.
Guidance, Outlook, and Risks
The filing explicitly states that the information furnished shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the registrant does not assume any obligation to update the information in the future. No specific guidance, outlook, or risk factors are detailed in this summary document.
Investor Verification Checklist
- Review the attached 2004 Annual Report (Exhibit 13.1) for actual financial performance data.
- Verify the contents of the concurrently mailed Notice of Annual Meeting and Proxy Statement.
- Confirm the filing status of the Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004.